Amanote Research
Register
Sign In
Real-Life Autologous Stem Cell Transplantation and Overall Survival Rates in Newly Diagnosed Multiple Myeloma Patients: An Analysis Based on a German Claims Dataset
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.04.125
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2018
Authors
S Mueller
T Wilke
U Maywald
A Groth
T Heidler
B Heeg
Publisher
Elsevier BV
Related search
High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Prognostic Nomogram for the Overall Survival of Patients With Newly Diagnosed Multiple Myeloma
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Impact of MiRSNPs on Survival and Progression in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Clinical Cancer Research
Cancer Research
Oncology
Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
Stem Cells International
Cell Biology
Molecular Biology
Health-Related Quality of Life After Autologous Stem Cell Transplantation for Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Genomic Aberrations and Survival of Patients With Light-Chain-Only Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Bortezomib-Based Regimens Used as Induction in Newly Diagnosed Multiple Myeloma (Ndmm) Patients Eligible for Stem Cell Transplantation (Sct)The Cost-Utility Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Quality of Life and Caregiver Burden in Multiple Myeloma and Lymphoma Patients Undergoing Outpatient Autologous Stem Cell Transplantation Versus Inpatient Transplantation
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Stem Cell Transplantation in Multiple Myeloma Patients <60 vs 60 Years of Age
Bone Marrow Transplantation
Transplantation
Hematology